320
Participants
Start Date
November 30, 2011
Primary Completion Date
March 31, 2014
Study Completion Date
July 31, 2015
BMS-650032
BMS-790052
BMS-791325
Ribavirin
Local Institution, Créteil
James J Peters Vamc, The Bronx
Local Institution, Marseille
Medstar Georgetown University Hospital, Washington D.C.
Johns Hopkins University, Lutherville
Mercy Medical Center, Inc., Baltimore
Metropolitan Research, Fairfax
Inova Fairfax Hospital, Falls Church
Atlanta Gastroenterology Associates, Llc, Atlanta
Orlando Immunology Center, Orlando
Miami Research Associates, South Miami
The Kirklin Clinic, Birmingham
Dean Clinic, Madison
Options Health Research, Llc, Tulsa
Healthcare Research Consultants, Tulsa
Local Institution, Paris
Texas Clinical Research Institute, Arlington
Research Specialists Of Texas, Houston
Alamo Medical Research, San Antonio
University Of Colorado Denver And Hospital, Aurora
Lifetree Clinical Research, Salt Lake City
Local Institution, Limoges
Southwest Care Center, Santa Fe
Peter J Ruane Md Inc, Los Angeles
Va Greater Los Angeles Healthcare System, Los Angeles
Research And Education, Inc., San Diego
Precision Research Institute, Llc, San Diego
Southern California Research Center, Coronado
Local Institution, Clichy
Medical Associates Research Group, San Diego
Id Care, Hillsborough
Fundacion De Investigacion De Diego, San Juan
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY